A Phase I Trial of the PI3K Inhibitor Buparlisib Combined With Capecitabine in Patients With Metastatic Breast Cancer
| Autor: | McRee, Autumn J., Marcom, Paul K., Moore, Dominic T., Zamboni, William C., Kornblum, Zachary A., Hu, Zhiyuan, Phipps, Rachel, Anders, Carey K., Reeder-Hayes, Katherine, Carey, Lisa A., Weck, Karen E., Perou, Charles M., Dees, E. Claire |
|---|---|
| Zdroj: | In Clinical Breast Cancer August 2018 18(4):289-297 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|
Full Text from ScienceDirect